TY -的AU - Ma,托尼AU - Chang,凯蒂盟——Alyusuf阿非盟- Bajracharya表示,依琳娜盟——Washio Yukiko AU -凯利,帕特里夏·J AU - Bellad鲁米非盟- Mahantashetti Niranjana年代盟——Charantimath Umesh AU -短,凡妮莎L盟——Lalakia Parth盟,Jaeger弗朗西斯盟——Goudar Shivaprasad盟德曼,理查德PY - 2022 DA - 2022/9/8 TI -设计、开发和测试BEST4Baby,移动医疗技术支持印度的纯母乳喂养:试点研究JO - JMIR Form Res SP - e32795 VL - 6 IS - 9 KW -移动健康KW -移动健康KW -同行咨询师KW -母乳喂养KW -农村KW -可用性KW -低收入和中等收入国家KW -灵活KW -任务转移KW -以用户为中心的设计KW -手机AB -背景:在包括印度在内的大多数低收入和中等收入国家，6个月大的纯母乳喂养(EBF)惊人地低。在低收入和中等收入国家，相对缺乏专门关注利用同伴咨询师(pc)来支持母亲的移动健康应用程序，以此作为增加EBF实践的一种手段。目的:本研究旨在设计、开发并测试婴儿母乳喂养教育支持工具(BEST4Baby)的可用性，这是一款移动健康应用程序，专门用于支持pc机为印度农村的母亲提供最佳母乳喂养实践的家庭母乳喂养咨询支持。方法:采用以用户为中心的敏捷开发方法进行设计。该方法涉及利益相关者和母亲，他们接受了培训，担任个人电脑，指导BEST4Baby的设计和开发，包括应用程序的内容和功能。pc通过互动线框的焦点小组参与。在为期24个月的试点研究期间，我们使用22台pc机对BEST4Baby应用程序进行了可行性测试，这些pc机支持对居住在印度农村的母亲进行家访。干预方案要求私人医生提供教育，并使用BEST4Baby应用程序跟踪母亲，从产前晚期到产后6个月进行9次定期家访。从pc的角度来看，BEST4Baby的可用性是使用翻译后的系统可用性量表(SUS)进行评估的。 Results: The findings of this study align with best practices in user-centered design (ie, understanding user experience, including context with iterative design with stakeholders) to address EBF barriers. This led to the cultural tailoring and contextual alignment of an evidence-based World Health Organization breastfeeding program with an iterative design and agile development of the BEST4Baby app. A total of 22 PCs tested and rated the BEST4Baby app as highly usable, with a mean SUS score of 85.3 (SD 9.1), placing it over the 95th percentile for SUS scores. The approach translated into a highly usable BEST4Baby app for use by PCs in breastfeeding counseling, which also statistically increased EBF practices. Conclusions: The findings suggest that BEST4Baby was highly usable and accepted by mothers serving as PCs to support other mothers in their EBF practices and led to positive outcomes in the intervention group’s EBF rates. The pilot study demonstrated that using the specially designed BEST4Baby app was an important support tool for mothers to serve as PCs during the 9 home visits. Trial Registration: Clinicaltrials.gov NCT03533725; https://clinicaltrials.gov/ct2/show/NCT03533725 SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/9/e32795 UR - https://doi.org/10.2196/32795 UR - http://www.ncbi.nlm.nih.gov/pubmed/36074546 DO - 10.2196/32795 ID - info:doi/10.2196/32795 ER -